Literature DB >> 9693275

Molecular cloning of IgE-binding fragments of Alternaria alternata allergens.

M W De Vouge1, A J Thaker, L Zhang, G Muradia, H Rode, H M Vijay.   

Abstract

Exposure to the hyphomycete Alternaria alternata is recognized as an important risk factor for asthma. IgE immunoblotting has been used to catalogue the number and Mr of allergens in A. alternata extracts, with estimates ranging from 10 to 30, although few are present in nearly all extracts studied. Several A. alternata allergens have been cloned, including a subunit of the major allergen Alt a 1, ribosomal P2 phosphoprotein, aldehyde dehydrogenase and a yeast YCP4 homolog. We have cloned two sequences encoding IgE-binding fragments of allergens from an A. alternata lambda gt11 cDNA library using pooled atopic sera from A. alternata-sensitive individuals. One is homologous to a region near the C-terminus of hsp70 from Cladosporium herbarum; a near-complete isoallergen variant of A. alternata ribosomal P2 protein was also cloned. Their lacZ fusion proteins had reactivities of 5 and 14%, respectively, with individual atopic sera, indicating that the corresponding allergens are both minor. This study describes one new A. alternata allergen candidate and implicates ribosomal P2 protein as an allergen thtat is stable between independently isolated clones.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9693275     DOI: 10.1159/000023954

Source DB:  PubMed          Journal:  Int Arch Allergy Immunol        ISSN: 1018-2438            Impact factor:   2.749


  10 in total

Review 1.  Cross-reactivity of plant and animal allergens.

Authors:  R W Weber
Journal:  Clin Rev Allergy Immunol       Date:  2001-10       Impact factor: 8.667

Review 2.  Serodiagnosis of mycoses using recombinant antigens.

Authors:  Natalia Elguezabal; Fernando Lopitz-Otsoa; Ana Laín; Iñigo Fernández de Larrinoa; María Dolores Moragues; José Pontón
Journal:  Mycopathologia       Date:  2005-09       Impact factor: 2.574

3.  Characterization of Cannabis sativa allergens.

Authors:  Ajay P Nayak; Brett J Green; Gordon Sussman; Noam Berlin; Hemant Lata; Suman Chandra; Mahmoud A ElSohly; Justin M Hettick; Donald H Beezhold
Journal:  Ann Allergy Asthma Immunol       Date:  2013-05-22       Impact factor: 6.347

Review 4.  Alternaria alternata and its allergens: a comprehensive review.

Authors:  Irena Kustrzeba-Wójcicka; Emilia Siwak; Grzegorz Terlecki; Anna Wolańczyk-Mędrala; Wojciech Mędrala
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

Review 5.  Fungal allergens.

Authors:  Viswanath P Kurup
Journal:  Curr Allergy Asthma Rep       Date:  2003-09       Impact factor: 4.806

6.  Production of the allergenic protein Alt a 1 by Alternaria isolates from working environments.

Authors:  Justyna Skóra; Anna Otlewska; Beata Gutarowska; Joanna Leszczyńska; Iwona Majak; Łukasz Stępień
Journal:  Int J Environ Res Public Health       Date:  2015-02-16       Impact factor: 3.390

Review 7.  Evaluation of Unconventional Protein Secretion by Saccharomyces cerevisiae and other Fungi.

Authors:  Natsuko Miura; Mitsuyoshi Ueda
Journal:  Cells       Date:  2018-08-31       Impact factor: 6.600

Review 8.  Alternaria as an Inducer of Allergic Sensitization.

Authors:  Guadalupe Hernandez-Ramirez; Domingo Barber; Jaime Tome-Amat; Maria Garrido-Arandia; Araceli Diaz-Perales
Journal:  J Fungi (Basel)       Date:  2021-10-07

9.  Biochemical and clinical studies of putative allergens to assess what distinguishes them from other non-allergenic proteins in the same family.

Authors:  Kevin C Glenn; Andre Silvanovich; Soon Goo Lee; Aron Allen; Stephanie Park; S Eliza Dunn; Colton Kessenich; Chen Meng; John L Vicini; Joseph M Jez
Journal:  Transgenic Res       Date:  2022-08-08       Impact factor: 3.145

10.  Innate Immunity Induced by the Major Allergen Alt a 1 From the Fungus Alternaria Is Dependent Upon Toll-Like Receptors 2/4 in Human Lung Epithelial Cells.

Authors:  Tristan Hayes; Amanda Rumore; Brad Howard; Xin He; Mengyao Luo; Sabina Wuenschmann; Martin Chapman; Shiv Kale; Liwu Li; Hirohito Kita; Christopher B Lawrence
Journal:  Front Immunol       Date:  2018-07-30       Impact factor: 7.561

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.